Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 150

1.

In vivo detection of short- and long-term MDMA neurotoxicity--a positron emission tomography study in the living baboon brain.

Scheffel U, Szabo Z, Mathews WB, Finley PA, Dannals RF, Ravert HT, Szabo K, Yuan J, Ricaurte GA.

Synapse. 1998 Jun;29(2):183-92.

PMID:
9593108
2.

Quantitative PET studies of the serotonin transporter in MDMA users and controls using [11C]McN5652 and [11C]DASB.

McCann UD, Szabo Z, Seckin E, Rosenblatt P, Mathews WB, Ravert HT, Dannals RF, Ricaurte GA.

Neuropsychopharmacology. 2005 Sep;30(9):1741-50.

3.

Positron emission tomography of 5-HT transporter sites in the baboon brain with [11C]McN5652.

Szabo Z, Scheffel U, Suehiro M, Dannals RF, Kim SE, Ravert HT, Ricaurte GA, Wagner HN Jr.

J Cereb Blood Flow Metab. 1995 Sep;15(5):798-805.

PMID:
7673372
4.

Positron emission tomography imaging of serotonin transporters in the human brain using [11C](+)McN5652.

Szabo Z, Kao PF, Scheffel U, Suehiro M, Mathews WB, Ravert HT, Musachio JL, Marenco S, Kim SE, Ricaurte GA, et al.

Synapse. 1995 May;20(1):37-43.

PMID:
7624828
5.

Comparison of (+)-(11)C-McN5652 and (11)C-DASB as serotonin transporter radioligands under various experimental conditions.

Szabo Z, McCann UD, Wilson AA, Scheffel U, Owonikoko T, Mathews WB, Ravert HT, Hilton J, Dannals RF, Ricaurte GA.

J Nucl Med. 2002 May;43(5):678-92. Erratum in: J Nucl Med 2002 Jun;43(6):744.

6.

A voxel-based PET investigation of the long-term effects of "Ecstasy" consumption on brain serotonin transporters.

Buchert R, Thomasius R, Wilke F, Petersen K, Nebeling B, Obrocki J, Schulze O, Schmidt U, Clausen M.

Am J Psychiatry. 2004 Jul;161(7):1181-9.

PMID:
15229049
7.

Toxicodynamics and long-term toxicity of the recreational drug, 3, 4-methylenedioxymethamphetamine (MDMA, 'Ecstasy').

Ricaurte GA, McCann UD, Szabo Z, Scheffel U.

Toxicol Lett. 2000 Mar 15;112-113:143-6. Review.

PMID:
10720723
8.

In vivo quantification of brain serotonin transporters in humans using [11C]McN 5652.

Parsey RV, Kegeles LS, Hwang DR, Simpson N, Abi-Dargham A, Mawlawi O, Slifstein M, Van Heertum RL, Mann JJ, Laruelle M.

J Nucl Med. 2000 Sep;41(9):1465-77. Erratum in: J Nucl Med 2000 Dec;41(12):1946.

9.

Positron emission tomography of 5-HT reuptake sites in the human brain with C-11 McN5652 extraction of characteristic images by artificial neural network analysis.

Szabo Z, Kao PF, Mathews WB, Ravert HT, Musachio JL, Scheffel U, Dannals RF.

Behav Brain Res. 1996;73(1-2):221-4.

PMID:
8788506
10.

Positron emission tomography imaging of the serotonin transporter in the pig brain using [11C](+)-McN5652 and S-([18F]fluoromethyl)-(+)-McN5652.

Brust P, Zessin J, Kuwabara H, Pawelke B, Kretzschmar M, Hinz R, Bergman J, Eskola O, Solin O, Steinbach J, Johannsen B.

Synapse. 2003 Feb;47(2):143-51.

PMID:
12454952
11.

Fenfluramine-induced loss of serotonin transporters in baboon brain visualized with PET.

Scheffel U, Szabo Z, Mathews WB, Finley PA, Yuan J, Callahan B, Hatzidimitriou G, Dannals RF, Ravert HT, Ricaurte GA.

Synapse. 1996 Dec;24(4):395-8.

PMID:
10638827
12.

Kinetic analysis of [11C]McN5652: a serotonin transporter radioligand.

Szabo Z, Scheffel U, Mathews WB, Ravert HT, Szabo K, Kraut M, Palmon S, Ricaurte GA, Dannals RF.

J Cereb Blood Flow Metab. 1999 Sep;19(9):967-81.

13.

Cortical serotonin transporter density and verbal memory in individuals who stopped using 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy"): preliminary findings.

Reneman L, Lavalaye J, Schmand B, de Wolff FA, van den Brink W, den Heeten GJ, Booij J.

Arch Gen Psychiatry. 2001 Oct;58(10):901-6.

PMID:
11576026
15.

Validity of [123I]beta-CIT SPECT in detecting MDMA-induced serotonergic neurotoxicity.

Reneman L, Booij J, Habraken JB, De Bruin K, Hatzidimitriou G, Den Heeten GJ, Ricaurte GA.

Synapse. 2002 Dec 1;46(3):199-205.

PMID:
12325046
16.

PET examination of three potent cocaine derivatives as specific radioligands for the serotonin transporter.

Helfenbein J, Sandell J, Halldin C, Chalon S, Emond P, Okubo Y, Chou YH, Frangin Y, Douziech L, Gareau L, Swahn CG, Besnard JC, Farde L, Guilloteau D.

Nucl Med Biol. 1999 Jul;26(5):491-9.

PMID:
10473187
17.

In vitro and in vivo characterisation of nor-beta-CIT: a potential radioligand for visualisation of the serotonin transporter in the brain.

Bergström KA, Halldin C, Hall H, Lundkvist C, Ginovart N, Swahn CG, Farde L.

Eur J Nucl Med. 1997 Jun;24(6):596-601.

PMID:
9169564
18.

N,N-dimethyl-2-(2-amino-4-(18)F-fluorophenylthio)-benzylamine (4-(18)F-ADAM): an improved PET radioligand for serotonin transporters.

Shiue GG, Choi SR, Fang P, Hou C, Acton PD, Cardi C, Saffer JR, Greenberg JH, Karp JS, Kung HF, Shiue CY.

J Nucl Med. 2003 Dec;44(12):1890-7.

19.

In vivo imaging of baboon and human dopamine transporters by positron emission tomography using [11C]WIN 35,428.

Wong DF, Yung B, Dannals RF, Shaya EK, Ravert HT, Chen CA, Chan B, Folio T, Scheffel U, Ricaurte GA, et al.

Synapse. 1993 Oct;15(2):130-42.

PMID:
8259524
20.

Supplemental Content

Support Center